Clinical advances in viral-vectored influenza vaccines

Clinical advances in viral-vectored influenza vaccines

Influenza-virus-mediated disease can be associated with high levels of morbidity and mortality, particularly in younger children and older adults. Vaccination is the primary intervention used to curb influenza virus infection, and the WHO recommends immunization for at-risk individuals to mitigate d...

Descripció completa

Dades bibliogràfiques
Autors principals:	Sebastian, S, Lambe, T
Format:	Journal article
Publicat:	MDPI 2018

Ítems similars

Clinical Advances in Viral-Vectored Influenza Vaccines
per: Sarah Sebastian, et al.
Publicat: (2018-05-01)

Viral vector vaccines
per: McCann, N, et al.
Publicat: (2022)

Clinical development of viral vectored vaccines against MERS-COV
per: Ewer, K, et al.
Publicat: (2018)

DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR
per: D. A. Mezhenskaia, et al.
Publicat: (2018-12-01)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
per: Bissett, C, et al.
Publicat: (2024)

Viral vectors as vaccine platforms: from immunogenicity to impact
per: Ewer (nee Russell), K, et al.
Publicat: (2016)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
per: Cameron Bissett, et al.
Publicat: (2024-06-01)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
per: Arunkumar, G, et al.
Publicat: (2019)

Research advances in replication-deficient viral vector vaccines
per: Junna Wang, et al.
Publicat: (2025-03-01)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
per: McMahon, M, et al.
Publicat: (2019)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
per: Antrobus, R
Publicat: (2014)

Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge
per: Tully, C, et al.
Publicat: (2017)

Towards the development of a universal influenza vaccine: investigating viral-vectored vaccine-induced heterosubtypic immune responses to influenza A
per: Tully, C
Publicat: (2015)

Evaluating the potential of novel virus-vectored vaccines as intranasal vaccine candidates for broad immunity against influenza
per: Mullin, J, et al.
Publicat: (2014)

Development of viral vectors for passive immunisation against influenza
per: Tan, TK
Publicat: (2017)

Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
per: Irina Isakova-Sivak, et al.
Publicat: (2022-07-01)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
per: Marta Ulaszewska, et al.
Publicat: (2023-01-01)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
per: Antrobus, R, et al.
Publicat: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
per: Antrobus, R, et al.
Publicat: (2014)

Adenoviral vectors as novel vaccines for influenza.
per: Coughlan, L, et al.
Publicat: (2015)

Viral vectors for malaria vaccine development.
per: Li, S, et al.
Publicat: (2007)

The use of viral vectors in vaccine development
per: Tatianna Travieso, et al.
Publicat: (2022-07-01)

Replicon RNA Viral Vectors as Vaccines
per: Kenneth Lundstrom
Publicat: (2016-11-01)

Developments in Viral Vector-Based Vaccines
per: Takehiro Ura, et al.
Publicat: (2014-07-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
per: Ewer (nee Russell), K, et al.
Publicat: (2017)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
per: Kapulu, MC
Publicat: (2014)

Recombinant influenza A viruses as vaccine vectors
per: Thomas Gerlach, et al.
Publicat: (2019-04-01)

Viral vectors as vaccine platforms: Deployment in sight
per: Rollier, C, et al.
Publicat: (2011)

Novel viral vector vaccines for tropical infections
per: Rampling, T
Publicat: (2017)

Viral vectors as vaccine platforms: deployment in sight.
per: Rollier, C, et al.
Publicat: (2011)

Viral Vectors for COVID-19 Vaccine Development
per: Kenneth Lundstrom
Publicat: (2021-02-01)

Viral Vector Vaccines against Bluetongue Virus
per: Luis Jiménez-Cabello, et al.
Publicat: (2020-12-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
per: Katie Ewer, et al.
Publicat: (2017-12-01)

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
per: Sushmita Kumari, et al.
Publicat: (2022-08-01)

Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines
per: Jianfeng Zhang
Publicat: (2012-11-01)

Advances in Adjuvanted Influenza Vaccines
per: Shintaro Shichinohe, et al.
Publicat: (2023-08-01)

Approaches to quality control, preclinical and clinical studies of live recombinant viral vector vaccines
per: L. M. Khantimirova, et al.
Publicat: (2021-12-01)

Developing viral vectored vaccines for MAGE-expressing tumours
per: McAuliffe, J
Publicat: (2020)

Baculovirus expression vector system for production of viral vaccines /
per: 300419 Vlak, J. M., et al.

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
per: Dulce Mata-Espinosa, et al.
Publicat: (2023-10-01)